Connor, Clark & Lunn Investment Management Ltd.

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1596800 VANCOUVER, A1

Position in CLDX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$4,481,125

-$1,358,653 QoQ

Shares Held

120,428

-34.6% QoQ

Ownership

0.153%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#74

of 252 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,455,383 across 105 Biotechnology names. CLDX ranks #33 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc.	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,481,125	120,428	-34.6%	Shares	Sole	2026-08-13
2026-03-31	$5,839,778	184,104	+55.7%	Shares	Sole	2026-05-11
2025-12-31	$3,210,447	118,205	+1348.9%	Shares	Sole	2026-02-10
2024-03-31	$342,391	8,158	-71.4%	Shares	Sole	2024-05-09
2023-12-31	$1,131,817	28,538	+57.2%	Shares	Sole	2024-02-09
2023-09-30	$499,625	18,155	-57.4%	Shares	Sole	2023-11-13
2023-03-31	$1,534,043	42,636	-26.4%	Shares	Sole	2023-05-10
2022-12-31	$2,581,048	57,910	-28.2%	Shares	Sole	2023-02-10
2022-09-30	$2,267,071	80,650	+565.6%	Shares	Sole	2022-11-10
2021-09-30	$654,196	12,117	-16.6%	Shares	Sole	2021-11-12
2021-06-30	$485,983	14,533	-61.1%	Shares	Sole	2021-08-12
2020-12-31	$654,301	37,346	-27.6%	Shares	Sole	2021-02-16
2020-09-30	$764,916	51,579	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.